InvestorsHub Logo

jbog

08/11/17 7:56 AM

#17579 RE: DewDiligence #17578

And do you see a similar situation with copaxone? We are seeing the larger generic company having a nightmare of a situation in generics right now. Only the very small, very cheap producers are benefiting.

(Impax)